Return to News >

Investors Dashboard

Britannia Life Sciences has established a unique position at the epicentre of some of the world’s most attractive markets.

We are currently servicing a diverse customer base and are strategically positioned to capitalize on growth opportunities in new markets and geographies. Our licenses, accreditations and experience allow us to provide our clients with an integrated service offering across the product development value chain.

An experienced management and operating team combined with our laboratory and technology platform are adaptable across a multitude of industries and geographies. Our strategy is to use this expertise, along with our relationships with clients, suppliers, industry groups and regulators to continue to grow our platform through both expansion and acquisition.

To discuss opportunities to work together or to learn more, please contact sarah@britannia.life.

CSE:BLAB

 0.00 (0.00%)

CAD $0.05

Fri Jul 19, 15:08 ET

Contact Investor Relations

Have a question for our Investor Relations team? We’re here to help.

CONTACT US

Depth Display By Order - 15:08:12

Bid broker Bid size Bid Price Ask Price Ask size Ask broker
Velocity Trade Capital Ltd. 85,000 0.05 0.09 20,000 Anonymous
Research Capital Corporation 254,000 0.05 0.10 54,000 RBC Capital Markets
National Bank Financial Inc. 2,000 0.05 0.10 14,000 Anonymous
TD Securities Inc. 2,000 0.04 0.15 12,000 iA Private Wealth Inc.
BMO Nesbitt Burns Inc. 7,000 0.04 0.18 15,000 iA Private Wealth Inc.
TD Securities Inc. 3,000 0.03 0.19 10,000 iA Private Wealth Inc.
CIBC World Markets Inc. 39,000 0.01 0.22 15,000 iA Private Wealth Inc.
0 0.00 0.23 10,000 iA Private Wealth Inc.
0 0.00 0.26 10,000 TD Securities Inc.
0 0.00 0.49 1,000 TD Securities Inc.

Depth Display By Price - 15:08:12

Bid count Bid size Bid Price Ask Price Ask size Ask count
3 341,000 0.05 0.09 20,000 1
2 9,000 0.04 0.10 54,000 1
1 3,000 0.03 0.10 14,000 1
1 39,000 0.01 0.15 12,000 1
0 0 0.00 0.18 15,000 1

Recent Trades - 07:00:00

Last 5 | Last 10 | Last 25

Date/Time Price Change Volume Buyer Seller
Jul 16, 11:40:29 0.05 3,000 BMO Nesbitt Burns Inc. TD Securities Inc.
Jul 16, 11:40:29 0.05 5,000 TD Securities Inc. TD Securities Inc.
Jul 15, 15:46:58 0.05 25,000 TD Securities Inc. TD Securities Inc.
Jul 12, 15:48:53 0.05 -0.015 10,000 TD Securities Inc. TD Securities Inc.
Jun 28, 09:37:12 0.07 -0.005 1,000 TD Securities Inc. RBC Capital Markets
Jun 28, 09:37:12 0.07 -0.005 15,000 National Bank Financial Inc. RBC Capital Markets
Jun 27, 12:02:46 0.07 0.020 26,000 BMO Nesbitt Burns Inc. TD Securities Inc.
Jun 26, 15:41:27 0.05 -0.020 10,000 TD Securities Inc. TD Securities Inc.
Jun 24, 14:46:08 0.07 1,000 BMO Nesbitt Burns Inc. Anonymous
Jun 24, 14:46:08 0.07 3,000 BMO Nesbitt Burns Inc. Anonymous
Jun 24, 14:46:08 0.07 13,000 BMO Nesbitt Burns Inc. Anonymous
Jun 24, 14:46:08 0.07 0.005 1,000 TD Securities Inc. Anonymous
Jun 24, 14:46:08 0.07 0.005 6,000 TD Securities Inc. Anonymous
Jun 24, 11:50:21 0.07 0.005 11,000 BMO Nesbitt Burns Inc. Anonymous
Jun 24, 10:33:49 0.08 0.010 4,000 Anonymous Anonymous
Jun 24, 10:33:49 0.09 0.015 4,000 Anonymous Anonymous
Jun 24, 09:30:00 0.09 0.015 4,000 National Bank Financial Inc. Anonymous
Jun 24, 09:30:00 0.09 0.015 4,000 National Bank Financial Inc. Anonymous
Jun 21, 13:06:12 0.07 0.015 8,000 BMO Nesbitt Burns Inc. TD Securities Inc.
Jun 21, 13:05:09 0.07 0.015 17,000 BMO Nesbitt Burns Inc. TD Securities Inc.
Jun 19, 13:58:46 0.06 -0.005 25,000 BMO Nesbitt Burns Inc. TD Securities Inc.
Jun 19, 12:48:55 0.06 -0.005 10,000 TD Securities Inc. TD Securities Inc.
Jun 13, 14:48:05 0.06 0.010 50,000 BMO Nesbitt Burns Inc. TD Securities Inc.
Jun 13, 12:30:46 0.05 50,000 TD Securities Inc. TD Securities Inc.
Jun 13, 10:28:32 0.05 1,000 Velocity Trade Capital Ltd. National Bank Financial Inc.
3

Year In Business

3

Locations

$7.8m

Annual Revenue (CAD)

28

Number of Employees

Investor News

Mark Bowes-Cavanagh appointed to Lead of Global Products Division

Mark Bowes-Cavanagh appointed to Lead of Global Products Division

Britannia Life Sciences Inc. is pleased to announce the appointment of Mark Bowes-Cavanagh as Chief Executive Officer of its Global Consumer Products Division. In...

Read more
BLS Joins Forces with ACI and ChemID to Facilitate UK CBD Market Access

BLS Joins Forces with ACI and ChemID to Facilitate UK CBD Market Access

Britannia Life Sciences Inc. is pleased to announce the launch of the Green Bridge Gateway, a strategic partnership between its subsidiary, Advanced Development...

Read more
Britannia Life Sciences Inc. Announces Second Quarter Results

Britannia Life Sciences Inc. Announces Second Quarter Results

Britannia Life Sciences Inc. is pleased to provide its unaudited financial results for the three- and six- month periods ended September 30, 2023. These filings and...

Read more
Update on Mining Division Including BMS and Paragon Geochemical

Update on Mining Division Including BMS and Paragon Geochemical

Britannia Life Sciences Inc. and its subsidiary, Britannia Mining Solutions Inc. are pleased to provide an update on its mining operations including Paragon...

Read more

    Subscribe to our Newsletter
     

    I agree that my submitted data is being collected and stored.

    Media Library

    Filter

    Categories

    Reset

    FAQ

    Shares of Britannia Life Sciences Inc. are traded on the Canadian Securities Exchange ticker symbol “BLAB”

    Shares of Britannia Life Sciences Inc. cannot be purchased directly from the company. From time to time the Company has sold shares directly to the public as part of its private placement process. There are investor requirements and certain exemptions which must be met to qualify. For more information about our private placements, please contact investors@britannia.life 

    Current share data can be found on the Canadian Securities Exchange under the ticker symbol “BLAB”

    Britannia Life Sciences Inc. does not comment on moves in its share price or offer investment advice

    Britannia Life Sciences Inc.’s transfer agent and registrar is TSX Trust Company, at its principal offices in 1 Toronto St, Suite 1200, Toronto, Ontario, Canada, M5C 2V6

    Britannia Life Sciences Inc. does not pay a dividend at this time

    As Britannia Life Sciences Inc. does not currently pay a dividend, the company does not offer a DRIP

    • If you are a registered stockholder and have questions regarding your holdings or if there are account changes to be made to the account (mailing address, account name, shareholder documentation requests), please contact Britannia Life Sciences Inc.’s transfer agent, TSX Trust Company here https://www.tsxtrust.com/
    • If you own shares through a brokerage account, contact the broker who is responsible for your account

    Britannia Life Sciences Inc.’s year end is March 31, 2021. Britannia Life Sciences Inc. issues its quarterly financial statements within 60 days of the quarter end, and its annual financial statements within 120 days of year-end

    Insider share ownership information is available on the System for Electronic Disclosure by Insiders (“SEDI”) at https://sedi.ca/

    The date and location of Britannia Life Sciences Inc.’s annual shareholder meeting varies from year to year. Britannia Life Sciences Inc. will publish a news release each year setting the date of the shareholders’ meeting. The location of the meeting will be in the notice of meeting and information circular mailed to shareholders and available on Britannia Life Sciences Inc. website

    You can find Britannia Life Sciences Inc.’s investor presentation here:

    Contact Info

    Canada
    120 Adelaide St. West, Suite 2400
    Toronto, Ontario
    Canada   M5H1T1

    E: enquiry@britannia.life

      Have a question?

      I agree that my submitted data is being collected and stored.

      Learn about Britannia Life Sciences at a glance with our corporate overview.

      DOWNLOAD PDF

      Investor Presentation Request Form

      Please fill out the following form to gain access to the Investor Presentation. You will receive an email confirmation containing a link to the requested file.

        Name

        Email

        Company Name (optional)

        Phone Number (optional)

        Get in Touch

        Get in touch with our team of professionals and let’s start a conversation.

          Information Request

          Name

          Email

          Company Name (optional)

          Phone Number (optional)

          Comments (optional)